MARKET

APVO

APVO

Aptevo
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.280
-0.250
-7.08%
Pre Market: 3.200 -0.08 -2.44% 08:13 04/03 EDT
OPEN
3.480
PREV CLOSE
3.530
HIGH
3.590
LOW
3.150
VOLUME
100.25K
TURNOVER
--
52 WEEK HIGH
14.56
52 WEEK LOW
2.944
MARKET CAP
10.61M
P/E (TTM)
-0.0163
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average APVO stock price target is 38.33 with a high estimate of 49.00 and a low estimate of 24.00.

EPS

APVO News

More
  • Aptevo Therapeutics EPS beats by $0.04, misses on revenue
  • seekingalpha · 03/25 18:10
  • Aptevo Therapeutics Reports 2019 Financial Results and Provides Business Update
  • ACCESSWIRE · 03/25 14:00
  • Aptevo Therapeutics Provides Update On Ongoing APVO436 Phase 1 Clinical Trial
  • ACCESSWIRE · 03/16 14:00
  • Aptevo Therapeutics Offers Update On Ongoing APVO436 Trial: Says Is Advancing On Schedule, Dosing In Cohort 6 To Begin Shortly
  • Benzinga · 03/16 13:07

Industry

Biotechnology & Medical Research
+3.32%
Pharmaceuticals & Medical Research
+2.80%

Hot Stocks

Symbol
Price
%Change

About APVO

Aptevo Therapeutics Inc. is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics. The Company's technology is the ADAPTIR (modular protein technology) platform. The Company has approximately four products in the areas of hematology and infectious diseases, as well as various investigational-stage product candidates in immuno-oncology. The Company's investigational-stage product candidates include MOR209/ES414, ES210, ES425, Otlertuzumab and 5E3. Its technology can produce monospecific and multispecific immunotherapeutic proteins that bind to various targets. The Company's marketed products are WinRho SDF (Rho(D) Immune Globulin Intravenous (Human)), HepaGam B (Hepatitis B Immune Globulin Intravenous (Human)) and VARIZIG (Varicella Zoster Immune Globulin (Human)).
More

Webull offers kinds of Aptevo Therapeutics Inc stock information, including NASDAQ:APVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APVO stock news, and many more online research tools to help you make informed decisions.